Archives
-
Hypoxia, S100A10, and GBM Chemoresistance
2026-08-24
The reference study identifies hypoxia-induced S100A10 as a driver of glioblastoma proliferation, glycolytic activity, apoptosis suppression, and temozolomide resistance through PI3K–AKT signaling. Its integrative use of public datasets, molecular assays, metabolic measurements, and cell-death analysis provides a framework for connecting tumor microenvironmental stress with treatment failure.
-
DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis
2026-08-23
The reference study introduces tetrahedral DNA nanostructures as an ordered interface that improves primer presentation, enzyme accessibility, and reaction performance in enzymatic oligonucleotide synthesis. Its TDN-based system reduced deletion errors in patterned sequences and achieved a reported 96.82% stepwise yield while encoding 15 bytes of text in a 60-nucleotide DNA fragment.
-
TPPU: Soluble Epoxide Hydrolase Inhibitor Workflows
2026-08-22
TPPU is a nanomolar soluble epoxide hydrolase inhibitor for connecting fatty acid epoxide signaling with inflammation, pain, redox biology, and osteoclastogenesis. This workflow-oriented guide shows how to prepare, apply, and troubleshoot TPPU in cellular, biochemical, and preclinical research without overstating translational maturity.
-
SW033291: 15-PGDH Inhibitor Workflows
2026-08-21
SW033291 provides a practical way to elevate prostaglandin E2 while testing 15-PGDH-dependent regeneration, hematopoiesis, and muscle repair pathways. This guide connects enzyme and cell assays with translational study designs, including the emerging combination of 15-PGDH inhibition and semaglutide during muscle recovery.
-
EZ Cap™ mCherry mRNA: Cap 1 Reporter
2026-08-20
EZ Cap™ mCherry mRNA is a capped red fluorescent protein mRNA designed for transient reporter expression with reduced innate immune stimulation. Its Cap 1 structure, 5mCTP and ψUTP substitutions, and approximately 100-nucleotide poly(A) tail support practical mRNA stability and translation enhancement.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-08-20
This study integrates patient observations, sepsis models in mice, and human microvascular endothelial-cell experiments to position moesin as a candidate marker of endothelial injury and disease severity. Its findings also connect circulating moesin with ROCK1/MLC and NF-κB signaling, providing a mechanistic basis for further biomarker and barrier-function research.
-
Annexin V-FITC/PI Apoptosis Assay Kit
2026-08-19
The Annexin V-FITC/PI Apoptosis Assay Kit supports rapid separation of viable, early apoptotic, and membrane-compromised cell populations using phosphatidylserine externalization and PI uptake. It is intended for research-use apoptosis assay workflows, not diagnostic testing or standalone identification of a specific cell-death mechanism.
-
Cytarabine (AraC) Workflows for Cell Death Research
2026-08-19
Build reproducible Cytarabine workflows that connect DNA synthesis blockade with dCK-dependent response, p53 signaling, and apoptotic readouts. The approach also shows how AraC experiments can be extended cautiously into virus-associated cell-death studies without confusing apoptosis with necroptosis.
-
LBP Activates Mitophagy to Protect Muscle in Obesity
2026-08-18
A 2025 study shows that Lycium barbarum polysaccharide (LBP) alleviates high-fat-diet-associated skeletal muscle atrophy by engaging the AMPK/PINK1/Parkin mitophagy pathway. Its combined mouse and cell-model evidence links improved glucose–lipid handling with mitochondrial quality control, while pharmacological and genetic perturbations support pathway dependence.
-
FH1 Small Molecule for iHep Maturation
2026-08-18
FH1 (Catalog No. B3700) supports more functional iPS-derived hepatocyte-like cultures by improving albumin secretion, CYP3A4 expression, colony morphology, and AFP profiles. This practical guide covers pilot dosing, maturation readouts, assay integration, and troubleshooting for liver cell research.
-
Cell Counting Kit-8 Plus: Mechanism and Workflow
2026-08-17
Cell Counting Kit-8 Plus is a WST-8-based tetrazolium salt assay for rapid, quantitative measurement of viable-cell-associated metabolic activity. Its sensitivity and short 0.5–1 hour assay window support cell proliferation assay, cytotoxicity assay, and drug screening workflows when results are interpreted within a validated linear range.
-
Dabigatran etexilate in Cell Assays
2026-08-17
Learn how Dabigatran etexilate (SKU A8381) can support mechanistic cell viability, proliferation, and cytotoxicity workflows involving thrombin-rich or plasma-containing systems. This scenario-based guide covers solvent compatibility, concentration design, data interpretation, and practical product-selection criteria.
-
Beyond G1 Arrest: Palbociclib and Cell-Death Logic
2026-08-16
PD 0332991 (Palbociclib) HCl is more than a tool for inducing G1 arrest. By combining selective CDK4/6 inhibition with emerging insight into RNA Pol II degradation-dependent apoptosis, translational researchers can distinguish cytostasis from cell death, sharpen biomarker strategies, and design more informative preclinical studies.
-
Norepinephrine bitartrate in translational workflows
2026-08-15
Learn how (-)-Norepinephrine (+)-bitartrate supports receptor assays, cardiomyopathy models, and quantitative vascular-response studies. A practical workflow connects fresh-solution handling with the VNERi concept from a 2025 septic-shock analysis while emphasizing assay controls and translational limits.
-
Epalrestat Activates KEAP1/Nrf2 in Parkinson’s Disease
2026-08-14
Jia et al. report that Epalrestat protects dopaminergic neurons in cellular and mouse Parkinson’s disease models by reducing oxidative stress and mitochondrial dysfunction. The study’s central innovation is evidence that this aldose reductase inhibitor directly engages KEAP1, promoting KEAP1 degradation and activating Nrf2, although the findings remain preclinical.